Russia vaccine announces increased efficacy Pfizer, but experts want to see the data: Sputnik V, one of the coronavirus vaccines promoted by Russia, has a 92% effectiveness in preventing infections, as reported by the Gamaleya Center and the Russian Direct Investment Fund (FIDR) and as reported by Reuters.

The announcement follows the one made this week by Pfizer and BioNTech, which assured that preliminary data from Phase 3 of their clinical trials show that their vaccine prevents contagion in 90% of cases.

As in the case of Pfizer, the results of the Russian vaccine have been reported by the center in charge of research, but still have not been published in a scientific journal after peer review.

Independent experts have warned that knowledge about the design and protocol of the trial is scarce, making it difficult to interpret the published figures.

"I see no reason a priori not to believe in these results, but it is very difficult to comment, because there is very little data," Danny Altmann, professor of Immunology at Imperial College London, tells Reuters.

In fact, the Russian vaccine has been generating controversy since it became the first to receive approval for its use without having completed all the tests that would have proven its safety and effectiveness.

Russia vaccine announces increased efficacy Pfizer

Isabel Sola, senior scientist and co-director along with Luis Rincanes of the coronavirus Laboratory of the National Biotechnology Center (CNB) of the Superior Council of Scientific Research (CSIC), said in a previous interview with Business Insider Spain that a government should not allow the commercialization of a vaccine that has not completed Phase 3 Tests.

In September the results of the first phases were published for the first time in the scientific journal The Lancet, assuring that it produced antibodies in all test volunteers.

A group of scientists later sent an open letter to the Journal questioning the publication and assuring that the data was " incomplete "and needed" clarification " and received a response from Russian researchers.

Phase 3 is being developed by the Gamaleya Institute and is being carried out in 29 clinics in Moscow, involving a total of 40,000 volunteers.

The vaccine is based on a human adenovirus vector and consists of two doses that are given three weeks apart.

Russia vaccine announces increased efficacy Pfizer

More news:

In Moscow you can spy on anyone for less than 200 euros thanks to the more than 100,000 surveillance cameras and facial recognition that are installed in the city

Moscow authorities are investigating illegal access to the facial recognition system flooding the Russian city. The searches have begun after a 20-year-old, digital rights activist, came across an ad on the network offering access to the surveillance system for only 16, 000 rubles, just about 170 euros.

Anna Kuznetsova, the name of this young lady, paid that amount. The announcement detailed that, in addition to the payment, it was necessary to send a photograph of the face of the person who wanted to spy. He sent a picture of himself. Within two days she received on her mobile a detailed list of locations in which she herself had been recorded by the Moscow facial recognition cameras.

This is what the Thomson Reuters Foundation tells, which interviews the collective that has uncovered this incident in the network of Russian cameras. "It was really amazing: we got a report with all the movements of Kuznetsova in Moscow," details a colleague of the activist, Sarkis Darbinyan, a lawyer in the collective of which both are part.

The city of Moscow has more than 105,000 video surveillance cameras. The authorities argue that it has served to lower the crime rate. Social rights advocates criticize that, on the contrary, these cameras have only served to monitor political dissent and there is a legal vacuum that allows their abuse.

To get the report that was spying on her, Kuznetsova only had to pay that 16,000 rubles after a brief conversation by Telegram. The cybercriminal who gave her access to more than 79 images the cameras had taken of her did not ask her any questions about why she wanted to access that data, or how she was going to use it.

The images give a clear idea of what the activist's home is, where her work is and what her daily routine is. "Any crazy guy can spy on you using this. Criminals can check when and where you go out to rob your apartment or hurt you. Anything can happen."

A startup has stolen billions of photos from Facebook and other websites to create a facial recognition database already used by police around the world

The Verge recalls that, although the Moscow surveillance system is one of the largest in the world, it is not the only one. He warns that the pharmaceutical chain Rite Aid has had recognition cameras in many of its stores for at least eight years.

In Spain something similar happens with Mercadona, which this summer surprisingly announced that it had installed this type of cameras in several of its establishments. Customers began to complain on the networks, the supermarket chain did not clarify at any time how they were going to use this technology —they argued that it was to prevent access to the premises of people with an order to remove them— and the AEPD began an investigation.

The Mercadona case also caught the attention of the European Data Protection Officer. He considered it"difficult to justify".

You may also find interesting: